Guidance moved higher again: Q2 lifted full-year MRD revenue to $268 million-$278 million from the prior $260 million-$270 million range, and tightened operating expense guidance to $350 million-$355 ...

As glucagon-like peptide-1 (GLP-1) receptor agonists become increasingly popular medications used to treat both type 2 ...

Overview• TAU researchers reanalyzed clinical trial data and found that the experimental drug Davunetide significantly slowed ...

Iran launched multiple ballistic missiles at U.S. forces in the Middle East in what U.S. Central Command described as an ...

Good day, and welcome to the Viking Therapeutics Second Quarter 2026 Financial Results Conference Call. [Operator Instructions] And as a reminder, this conference call is being recorded today, July 29 ...

The growing uncertainty over the future of the Portland Trail Blazers and the complicated political and financial negotiations seems never-ending. The Athletic reported on Monday that it’s unclear ...

AI is shifting life sciences M&A risk from early milestones to later validation, reshaping valuation, diligence, and deal ...

The image. Kicks. Number Ones. Orange leader. The Cliffords. How many times in your life can you truly say that there is ...

Key Points Interested in Adaptive Biotechnologies Corporation? Here are five stocks we like better. Revenue and MRD growth ...

EA FC 27 Gameplay Details have emerged, showing off updated PlayStyles, improvements to offense and defense, and much more.

Q2 2026 revenues of $4.1 billion decreased by 1% in U.S. dollars year-over-year (YoY) and by 3% in local currency (LC) terms, mainly due to lower generics revenues. Our key ...

The condition of bones in old age largely depends on the reserve of bone mass formed in childhood and youth. However, nutrition, physical activity, and lifestyle continue to influence the rate of ...